ViaDerma, Inc. (VDRM)
OTCMKTS
· Delayed Price · Currency is USD
0.0120
+0.0003 (2.56%)
Apr 25, 2025, 4:00 PM EDT
ViaDerma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2017 | FY 2016 | FY 2015 | FY 2011 | FY 2010 | 2007 - 2009 |
|---|---|---|---|---|---|---|
Period Ending | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | 2007 - 2009 |
| Revenue | 0.04 | 0.25 | 0.19 | 19.01 | 26.83 | Upgrade
|
| Revenue Growth (YoY) | -82.26% | 31.39% | -98.99% | -29.15% | 6.20% | Upgrade
|
| Cost of Revenue | 0.01 | 0.01 | 0.02 | 13.35 | 16.68 | Upgrade
|
| Gross Profit | 0.04 | 0.24 | 0.18 | 5.66 | 10.15 | Upgrade
|
| Selling, General & Admin | 0.49 | 0.11 | 0.04 | 1.62 | 2.38 | Upgrade
|
| Operating Expenses | 0.63 | 0.11 | 0.08 | 1.62 | 2.38 | Upgrade
|
| Operating Income | -0.59 | 0.13 | 0.09 | 4.04 | 7.77 | Upgrade
|
| Interest Expense | -0.39 | -0.25 | -0.12 | -0.5 | -1.27 | Upgrade
|
| Interest & Investment Income | - | - | - | 0.01 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.53 | -0.02 | 0.05 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -1.52 | -0.14 | 0.03 | 3.55 | 6.5 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0 | -0 | Upgrade
|
| Other Unusual Items | - | 0.02 | - | - | - | Upgrade
|
| Pretax Income | -1.52 | -0.12 | 0.03 | 3.55 | 6.5 | Upgrade
|
| Income Tax Expense | - | - | - | 0.87 | 1.99 | Upgrade
|
| Net Income | -1.52 | -0.12 | 0.03 | 2.67 | 4.51 | Upgrade
|
| Net Income to Common | -1.52 | -0.12 | 0.03 | 2.67 | 4.51 | Upgrade
|
| Net Income Growth | - | - | -98.98% | -40.70% | 10.07% | Upgrade
|
| Shares Outstanding (Basic) | 376 | 161 | 104 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 376 | 161 | 104 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 133.98% | 55.10% | 75400.79% | - | -0.76% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | 0.00 | 19.46 | 32.82 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | 0.00 | 19.46 | 32.82 | Upgrade
|
| EPS Growth | - | - | -100.00% | -40.70% | 11.25% | Upgrade
|
| Free Cash Flow | -0.17 | -0.01 | -0.01 | -3.38 | 0.65 | Upgrade
|
| Free Cash Flow Per Share | - | - | - | -24.60 | 4.74 | Upgrade
|
| Gross Margin | 84.20% | 95.74% | 91.66% | 29.79% | 37.82% | Upgrade
|
| Operating Margin | -1327.78% | 50.58% | 48.88% | 21.25% | 28.95% | Upgrade
|
| Profit Margin | -3397.52% | -48.34% | 14.14% | 14.06% | 16.80% | Upgrade
|
| Free Cash Flow Margin | -374.49% | -4.79% | -5.83% | -17.77% | 2.43% | Upgrade
|
| EBITDA | -0.59 | 0.13 | 0.09 | 6.85 | 9.33 | Upgrade
|
| EBITDA Margin | - | 50.96% | 49.39% | 36.02% | 34.76% | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | 2.81 | 1.56 | Upgrade
|
| EBIT | -0.59 | 0.13 | 0.09 | 4.04 | 7.77 | Upgrade
|
| EBIT Margin | - | 50.58% | 48.88% | 21.25% | 28.95% | Upgrade
|
| Effective Tax Rate | - | - | - | 24.65% | 30.66% | Upgrade
|
| Revenue as Reported | 0.04 | 0.25 | 0.19 | - | - | Upgrade
|
| Advertising Expenses | 0.01 | - | 0.01 | - | - | Upgrade
|
Updated May 3, 2018. Source: S&P Global Market Intelligence. Standard template. Financial Sources.